The Food and Drug Administration (FDA) issued the July Interstate Certified Shellfish Shippers List (ICSSL). The ICSSL is published monthly for the information and use by food control officers, the seafood industry and other interested persons. The shippers listed have been certified by regulatory authorities in the United States, Canada, Chile, Korea, Mexico and New Zealand under the uniform sanitation requirements of the National Shellfish Program.
On July 6 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
On July 5 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Food and Drug Administration issued its weekly Enforcement Report for July 5 that lists the status of recalls and field corrections for food, drugs, biologics, and devices. The report covers both domestic and foreign firms.
The Food and Drug Administration issued its proposed rule to require unique device identifiers (UDIs) on the labels of medical devices and device packages, with certain exceptions. The proposed rule, which would implement requirements added to the Federal Food, Drug, and Cosmetic Act by Section 226 of the Food and Drug Administration Amendments Act of 2007, is scheduled to be published in the July 10 Federal Register. Comments on the FDA’s proposed rule are due by about Nov. 7. Comments on new information collection requirements contained in the proposed rule are due by Sept. 10.
On July 3 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Food and Drug Administration amended its requirements for D&C Red No. 6 and D&C Red No. 7 by replacing the current specification for “Ether-soluble matter” with a maximum limit of 0.015 percent for the recently identified impurity 1-[(4-methylphenyl)azo]-2-naphthalenol, in response to a petition filed by Sun Chemical Corp, it said in a final rule. The rule is effective August 7, 2012, except for any provisions that may be stayed by the filing of proper objections. Such objections and requests for hearings may be submitted by August 6, 2012.
A premarket approval application (PMA) or a notice of completion of a product development protocol (PDP) will be required for cardiovascular permanent pacemaker electrodes, said the Food and Drug Administration in a final rule.
On July 2 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:
During the week of June 25 - July 1, the Food and Drug Administration modified the following existing Import Alerts (not otherwise listed on the FDA's new and revised import alerts page) on the detention without physical examination of: